A US federal appeals court panel has unanimously dismissed an attempt by Johnson & Johnson to use a controversial procedure that could resolve claims from lawsuits...
02.09.2014
- The first half suggests that 2014 will be a record year for M&A in pharmaceuticals, with the size of deals having increased substantially over prior years. In 2011, the deal volume...
08.09.2010
- Merck said an arbitration panel would look in late September at whether the company is entitled to overseas rights to Remicade and Simponi, Johnson & Johnson's important rheumatoid...
